Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03442049
Other study ID # GO 14/633
Secondary ID
Status Completed
Phase N/A
First received January 25, 2018
Last updated February 15, 2018
Start date January 1, 2015
Est. completion date May 1, 2016

Study information

Verified date February 2018
Source Hacettepe University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Gait and mobility are among the functions frequently affected in Multiple Sclerosis (MS) and have a negative impact on quality of life. Strength losses in lower limb muscles, ataxia, sensory problems and fatigue are the most important reasons of walking problems in patients with MS. In addition to loss of strength and tonus problems, especially biomechanical disorders can be seen on foot and this problem affects gatin and balance negatively. The stabilizing muscles, defined as the "core" region and enveloping the body like a corset, are active in the context of postural preparation prior to lower extremity movements and stabilize for the limb movements to be performed. The aim of this study was to investigate the effects of spinal stabilization exercises on walking performance, fatigue, plantar pressure distribution, balance, muscle strength and quality of life in patients with Multiple Sclerosis.


Recruitment information / eligibility

Status Completed
Enrollment 68
Est. completion date May 1, 2016
Est. primary completion date February 20, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Older than 18 years old

- EDSS score is between 3-5,5

- Patients who did not take corticosteroid therapy within three months

- Patients who get at least 24 points from the Mini Mental Test were included in the study.

Exclusion Criteria:

- Patients who had an acute MS attack or had an attack within the last three months.

- An orthopedic or systemic problem that would prevent participation in exercises

- Patients who were using walking orthoses or walking aids were not included in the study.

Study Design


Intervention

Other:
Physiotherapy - Study group
Study group : In addition to home program spinal stabilization exercises
Physiotherapy - control group
Home exercise program

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Hacettepe University

References & Publications (5)

Bethoux F. Gait disorders in multiple sclerosis. Continuum (Minneap Minn). 2013 Aug;19(4 Multiple Sclerosis):1007-22. doi: 10.1212/01.CON.0000433286.92596.d5. Review. — View Citation

Freeman J, Fox E, Gear M, Hough A. Pilates based core stability training in ambulant individuals with multiple sclerosis: protocol for a multi-centre randomised controlled trial. BMC Neurol. 2012 Apr 5;12:19. doi: 10.1186/1471-2377-12-19. — View Citation

Freeman JA, Gear M, Pauli A, Cowan P, Finnigan C, Hunter H, Mobberley C, Nock A, Sims R, Thain J. The effect of core stability training on balance and mobility in ambulant individuals with multiple sclerosis: a multi-centre series of single case studies. Mult Scler. 2010 Nov;16(11):1377-84. doi: 10.1177/1352458510378126. Epub 2010 Aug 10. — View Citation

Givon U, Zeilig G, Achiron A. Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation system. Gait Posture. 2009 Jan;29(1):138-42. doi: 10.1016/j.gaitpost.2008.07.011. Epub 2008 Oct 31. — View Citation

Hides J, Wilson S, Stanton W, McMahon S, Keto H, McMahon K, Bryant M, Richardson C. An MRI investigation into the function of the transversus abdominis muscle during "drawing-in" of the abdominal wall. Spine (Phila Pa 1976). 2006 Mar 15;31(6):E175-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary 6 Minutes Walk Test Maximum Walking Distance in 6 Minutes Change from Baseline 6 Minutes Walking Distance at 6 weeks.
Primary Modified Borg Scale Evaluating fatigue between the scores of 0 and 10. "0" means no fatigue at all. "10" means maximal fatigue. Change from Baseline Fatigue Score at 6 weeks.
Primary Plantar Pressure Distribution Peak pressure values of 10 subregions under the foot Change from baseline peak pressure and contact area values at 6 weeks
Primary Plantar Pressure Distribution Contact area values of 10 subregions under the foot Change from baseline peak pressure and contact area values at 6 weeks
Primary Multiple Sclerosis Quality of Life Scale Quality of life assessment with 54 questions about mental and physical health in daily life activities. Change from baseline mental and physical quality of life scores at 6 weeks
Secondary Muscle strength with hand held dynamometer Hip Flexors Muscle Strength Change from baseline muscle strength at 6 weeks
Secondary Muscle strength with hand held dynamometer Hip Abductors Muscle Strength Change from baseline muscle strength at 6 weeks
Secondary Muscle strength with hand held dynamometer Knee Flexors Muscle Strength Change from baseline muscle strength at 6 weeks
Secondary Muscle strength with hand held dynamometer Knee Extensors Muscle Strength Change from baseline muscle strength at 6 weeks
Secondary Muscle strength with hand held dynamometer Ankle Dorsiflexors Muscle Strength Change from baseline muscle strength at 6 weeks
Secondary MiniBESTest Static and dynamic balance evaluation. This test includes 14 items and maximum score is 28. 28 points means best balance status. Change from baseline MiniBESTest scores at 6 weeks
Secondary Dynamic Gait Index Dynamic balance evaluation especially walking balance. This test includes 8 items and maximum score is 24. Maximum score means best dynamic balance status. Change from baseline Dynamic Gait Index scores at 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4